9th Annual Biomarkers Congress

Schedule of Presentations:

Tuesday, November 6, 2007
12:00:00 New Presentation
12:00:00 New Presentation
12:00:00 New Presentation
12:00:00 New Presentation
12:00:00 New Presentation
15:30:00 POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER Birte Wistinghausen
15:30:00 PEDIATRIC ONCOLOGY Gustavo Del Toro
15:45:00 RECENT CLINICAL TRIALS IN ACUTE PROMYELOCYTIC LEUKEMIA John Gregory
16:00:00 IDENTIFYING PATIENTS AT RISK FOR TUMOR LYSIS SYNDROME Scott Howard
16:15:00 TREATMENT OF RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA Glen Lew
16:30:00 CHEMOIMMUNOTHERAPY REINDUCTION WITH EPRATUZUMAB IN CHILDREN WITH RELAPSED ALL Elizabeth Raetz
16:45:00 HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ALL David A. Jacobsohn
17:00:00 PSYCHO-SOCIAL OUTCOMES IN PEDIATRIC ONCOLOGY PATIENTS Stephen A. Sands
17:15:00 Discussion
19:00:00 PEDIATRIC ONCOLOGY ADVANCES IN 2007 NOVEL STRATEGIES FOR RELAPSED CHILDHOOD LEUKEMIA Sima Jeha
19:00:00 Dinner & Special Presentation
Wednesday, November 7, 2007
07:00:00 CURRENT & FUTURE TARGETED THERAPIES Michael J. Mauro
07:00:00 CURRENT & FUTURE TARGETED THERAPIES Moshe Talpaz
07:00:00 Breakfast with the Professors
08:00:00 MORNING SESSION HEMATOLOGIC MALIGNANCIES Janet Cuttner, Janice L. , Gabrilove, George F. Atweh
08:00:00 WELCOME Janice L. , Gabrilove, George F. Atweh, Edward P. Ambinder
08:15:00 FLAVOPIRODOL: A NOVEL THERAPEUTIC FOR CLL Janice L. , Gabrilove
08:30:00 RISK-ADAPTED THERAPEUTIC OPTIONS IN CLL Kanti R. Rai
08:45:00 SECOND & THIRD GENERATION TYROSINE KINASE INHIBITORS in CML Hagop M. Kantarjian
08:55:00 AML IN THE ELDERLY: A PROBLEM WITH SOME SOLUTIONS Hagop M. Kantarjian
09:05:00 NOVEL THERAPEUTICS IN AML Gail J Roboz
09:15:00 NEW OPTIONS IN ELDERLY NAÏVE AND RELAPSED AML Harry P. Erba
09:25:00 ROLE OF EPIGENETIC THERAPY IN AML William Blum
09:35:00 UPDATE ON TREATMENT OPTIONS IN MDS AND AML Guillermo Garcia-Manero
09:45:00 ASPARAGINE DEPLETION IN TREATMENT OF ADULTS WITH ALL Daniel J. DeAngelo
09:55:00 LENALIDOMIDE IN MDS: UPDATE ON NON DEL 5Q PATIENTS Gail J Roboz
10:05:00 Coffee Time
10:35:00 NOVEL THERAPIES FOR MANTLE CELL LYMPHOMA Michael Wang
10:45:00 BORTEZOMIB & SM-153 LEXIDRONAM COMBINATION THERAPY IN MUTIPLE MYELOMA James R. Berenson
10:55:00 RITUXIMAB COMBINATIONS IN NHL John P. Leonard
11:05:00 LENALIDOMIDE IN PLASMA CELL DYSCRASIAS S. Vincent Rajkumar
11:15:00 CP-4055, A NOVEL NUCELOSIDE ANALOG Frank J. Giles
11:25:00 NILOTINIB: A HIGHLY SPECIFIC BCR-ABL INHIBITOR Frank J. Giles
11:35:00 UPDATE ON GALIXIMAB: ANTI-CD80 MONOCLONAL ANTIBODY Myron S. Czuczman
11:45:00 Discussion
12:00:00 MOLECULAR TARGETED THERAPIES IN HEPATOCELLULAR CARCINOMA: ROLE OF SORAFENIB Josep Llovet
12:00:00 Novel Approaches to Diagnosis and Management of Thrombocytopenia James B. Bussel
12:00:00 THE INTEGRATION OF NOVEL AGENTS IN CHEMORADIATION FOR RECTAL CANCER Lisa A. Kachnic
12:00:00 Lunch and Presentations Educational Grant: Amgen John Glaspy
13:30:00 BREAST CANCER PREVENTION AND THE NSABP CLINICAL TRIALS Norman Wolmark
13:50:00 DOES BEVACIZUMAB WORK EQUALLY WELL WITH ALL CHEMOTHERAPY DRUGS? CONFLICTING VIEWS Leonard B. Saltz, Axel Grothey
14:05:00 INTEGRATION OF BIOLOGICAL AGENTS FOR ADVAN CED COLORECTAL CANCER Edward Chu
14:15:00 EXPANDING ROLE OF CETUXIMAB IN THE FIRST AND SECOND-LINE THERAPY OF COLORECTAL CANCER Howard S. Hochster
14:25:00 CLINICAL TRIALS OF SMALL MOLECULE INHIBITORS IN CRC Mace Rothenberg
14:35:00 RADIOIMMUNOTHERAPY POST SALVAGE RESECTION OF COLORECTAL LIVER METASTASES David M. Goldenberg
15:05:00 Coffee Time
15:35:00 NEW STANDARD THERAPY FOR GASTRIC CANCER Wasaburo Koizumi
15:45:00 ADVANCES IN THE TREATMENT OF ESOPHAGOGASTRIC CANCER David H. Ilson
15:55:00 MULTIMODALITY TREATMENT OF GALL BLADDER CANCER Jorge Gallardo
16:05:00 GIST: TARGETING PATHOGENIC PATHWAYS AND DEVELOPING NEW AGENTS George Daniel Demetri
16:15:00 RAV12 FOR GI CANCERS: A NOVEL CYTOTOXIC MONOCLONAL ANTIBODY Howard A. Burris
16:25:00 PANITUMUMAB: DIFFERENT ANTIBODY OR THE SAME THING, DIFFERENT RESULTS? Jordan Berlin
16:35:00 XALIPRODEN: PREVENTING OXALIPLATIN NEUROTOXICITY Robert J. Jones
16:45:00 Discussion
16:55:00 HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) IN GASTRIC CANCER Daniel M. Labow
19:00:00 Educational Grant: Cephalon RELAPSED AND REFRACTORY LYMPHOMAS Philip Cohen
19:00:00 Dinner Presentation
19:00:00 Options: Non-Hodgkin's lymphoma Jonathan W. Friedberg
Thursday, November 8, 2007
07:00:00 Breakfast with the Professors Educational Grant: Pfizer Oncology Mace Rothenberg, Paulo M. Hoff
08:00:00 PEGYLATED LIPOSOMAL DOXORUBICIN: DOSE-SCHEDULING, COMBINATIONS AND MAINTENANCE Franco M. Muggia
08:15:00 IS HEREDITARY OVARIAN CANCER MORE RESPONSIVE TO CHEMOTHERAPY? REVIEWING THE EVIDENCE Tamar Safra
08:30:00 NEW AGENTS IN OVARIAN CANCR Carol Aghajanian
08:45:00 ROLE OF INTRAPERITONEAL DRUG DELIVERY IN THE MANAGEMENT OF OVARIAN CANCER Maurie Markman
09:00:00 IP CARBOPLATIN-BASED CHEMOTHERAPY FOR OVARIAN CANCER Keiichi Fujiwara
09:15:00 BIOMARKERS FOR OVARIAN CANCER Robert C Bast
09:30:00 THE GOG TRIALS Thomas J. Herzog
09:45:00 OVERVIEW OF NATIONAL & INTERNATIONAL PHASE III William P. McGuire
10:00:00 TRABECTEDIN IN RELAPSED OVARIAN CANCER Carolyn Krasner
10:15:00 ISSUES IN CERVICAL CANCER Bradley J Monk
10:30:00 Coffee Time
11:00:00 Discussion
11:15:00 HEAD AND NECK CANCER EMERGING SYSTEMIC THERAPIES Ezra E.W. Cohen
11:30:00 THYROID CANCER NOVEL IMMUNOTHERAPY Gregory T. Wolf
11:40:00 NEW DEVELOPMENTS IN TARGETED THERAPY David G. Pfister
11:55:00 Discussion
12:00:00 ROLE OF TOPOTECAN IN THE MANAGEMENT OF Tamar Safra
12:00:00 Dinner & Special Presentation Educational Grant: Genomic Health Hope S. Rugo, Andrew Seidman
12:00:00 NOVEL STRATEGIES TARGETING VEGF RECEPTORS Mark Pegram
12:00:00 Lunch & Presentation
13:30:00 BREAST CANCER James F. Holland
14:00:00 NEXT GENERATION HERCEPTIN - THE TRASTUZUMAB DM-1 Howard A. Burris
14:15:00 ANTI-HER2 THERAPY: BEYOND TRASTUZUMAB Clifford A. Hudis
14:30:00 CLINICAL UPDATE ON A 2ND GENERATION EPOTHILONE KOS1584 Howard A. Burris
14:45:00 LAPATINIB/PACLITAXEL FOR INFLAMMATORY BREAST CANCER Massimo Cristofanilli
14:55:00 EGFR INHIBITION WITH LAPATINIB IN COMBINATION WITH VINORELBINE: A PHASE I STUDY Helen K. Chew
15:00:00 Coffee Time
15:20:00 RANDOMIZED PHASE II TRIAL OF PACLITAXEL WITH OR WITHOUT STA 4783 IN METASTATIC MELANOMA David Lawson
15:30:00 RATIONAL DESIGN OF DOSE AND SCHEDULE OF Larry Norton
15:45:00 CLINICAL ACTIVITY OF CAPECITABINE PLUS William J. Gradishar
15:55:00 TYPE I INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF1R) Deepali Sachdev
16:05:00 SERUM HER-2/NEU AS A PREDICTOR OF RESPONSE TO Allan Lipton
16:15:00 CLINICAL APPLICATION OF MOLECULAR PROFILING Joseph Sparano
16:25:00 RECENT CHANGES IN INCIDENCE AND MORTALITY IN THE US Peter Ravdin
16:35:00 SYSTEMIC THERAPY FOR BREAST CANCER BRAIN METASTASES Nancy U. Lin
16:45:00 Discussion
Friday, November 9, 2007
07:00:00 Breakfast with the Professors Educational Grant: Abraxis Bioscience & AstraZeneca
07:00:00 MODULATING DRUG RESISTANCE Edith A Perez
07:00:00 NEW TAXANE ALTERNATIVES Management of Toxicity Hope S. Rugo
08:00:00 SATRAPLATIN UPDATE A. Oliver Sartor
08:10:00 ANTI-TUMOR ACTIVITY OF ABIRATERONE ACETATE IN CASTRATION-RESISTANT PROSTATE CANCER Daniel Danila
08:20:00 GVAX IN PROSTATE CANCER Michael A Carducci
08:30:00 NEW AGENTS AND COMBINATIONS Anna C. Ferrari
08:40:00 Discussion
08:55:00 RAD001 IN RENAL CELL CANCER Jaroslaw Jac
09:05:00 SUNITINIB IN RENAL CELL CANCER: EXPANDED ACCESS Janice P. Dutcher
09:15:00 PHASE II CLINICAL DATA ON PAZOPANIB Robert A. Figlin
09:25:00 PERIFOSINE: ORALLY ACTIVE AKT INHIBITOR WITH INTRIGUING ACTIVITY IN METASTIC RENAL CANCER Nicholas J. Vogelzang
09:35:00 APAZIQUONE - A NEW AGENT FOR ADJUVANT THERAPY IN NON-INVASIVE BLADDER CANCER Daniel Saltzstein
09:45:00 Discussion
09:55:00 Coffee Time
10:25:00 BIOLOGIC SELECTION MARKERS FOR EGFR TKIS Paul A. Bunn
10:40:00 NSCLC: VEGFR TARGETED AGENTS BEYOND BEVACIZUMAB Chandra P. Belani
10:55:00 AMRUBICIN IN SCLC Robert M. Jotte
11:05:00 SUNITINIB IN LUNG CANCER Mark A. Socinski
11:10:00 SUNITINIB IN LUNG CANCER Mark A. Socinski
11:15:00 NON-SMOKERS: NSCLC Nasser H. Hanna
11:25:00 AIRWAY GENE EXPRESSION AS A NOVEL DIAGNOSTIC BIOMARKER FOR LUNG CANCER Avrum Spira
11:35:00 UPDATE ON ELDERLY AND PS 2 PATIENTS WITH ADVANCED NSCLC Rogerio Lilenbaum
11:45:00 Discussion
12:00:00 Noon Lunch & Presentation Educational Grant: GPC Biotech Daniel P. Petrylak
13:00:00 RADIOEMBOLIZATION FOR NEUROENDOCRINE HEPATIC METASTASES Andrew S. Kennedy
13:10:00 PHASE II STUDY OF RAD001 (EVEROLIMUS) AND DEPOT OCTREOTIDE IN ADVANCED LOW GRADE NEUROENDOCRINE CARCINOMA Alexandria Phan
13:20:00 BEVACIZUMAB FOR MALIGNANT GLIOMAS: RESULTS AND FUTURE DIRECTIONS Mark R. Gilbert
13:30:00 TERAMEPROCOL: A NOVEL TREATMENT APPROACH Stuart Grossman
13:40:00 AEROSOLIZED GM-CSF Svetomir N. Markovic
13:50:00 TEMOZOLOMIDE AND SORAFENIB FOR PATIENTS WITH OR WITHOUT BRAIN METASTASES: PHASE II RESULTS Ravi Amaravadi
14:00:00 REGIONAL TREATMENT STRATEGIES FOR PATIENTS WITH HEPATIC METASTASES FROM MELANOMA James , Pingpank
14:10:00 PRELIMINARY RESULTS OF GENASENSE, TEMOZOLOMIDE & ABRAXANE COMBINATION IN ADVANCED MELANOMA Anna Pavlick
14:20:00 DENOSUMAB IN BREAST & PROSTATE CANCER Allan Lipton
14:30:00 TARGETING DEATH RECEPTORS WITH AGNOSTIC MONOCLONAL ANTIBODIES Roger B. Cohen
14:40:00 Discussion
14:50:00 Coffee Time
15:05:00 MARQIBO IN ADULT LYMPHOBLASTIC LEUKEMIA
15:20:00 RANDOMIZED PHASE II TRIAL OF PACLITAXEL WITH OR WITHOUT STA 4783 IN METASTATIC MELANOMA David Lawson
15:30:00 MOVING SCIENCE TO THE CLINIC: APL AND EPIGENETIC THERAPY Samuel Waxman
15:45:00 CANCER VACCINES: TODAY AND TOMORROW Jeffrey Schlom
16:00:00 TUMOR MOLECULAR PROFILING: PERSONALIZING THERAPY Ari Melnick
16:15:00 TARGETED THERAPIES – THE NEXT WAVE Charles L Sawyers
16:30:00 DORMANT CANCER CELLS: THE ROOT CAUSE? Julio Aguirre-Ghiso
16:35:00 Panel Discussion
19:00:00 Dinner & Special Presentations Educational Grant: Bayer HealthCare/Onyx Pharmaceuticals Ghassan K Abou-Alfa, Andrew Zhu
Saturday, November 10, 2007
07:00:00 REGISTRATION AND CONTINENTAL BREAKFAST
08:00:00 OPENING REMARKS Co-Chair
08:10:00 AM MEETING GOALS
08:15:00 AM THE THREATENING SHORTAGE OF ONCOLOGISTS- HOW WILL THIS AFFECT THE ROLE OF THE NON-PHYSICIAN CLINICIAN?
08:35:00 AM THE TREATMENT OF PEDIATRIC LEUKEMIA
08:55:00 MEDICATION SAFETY: FOCUS ON CHEMOTHERAPY NEAR-MISSES
09:15:00 IP THERAPY: A CHALLENGING APPROACH TO IMPROVING SURVIVAL IN OVARIAN CANCER
09:35:00 THE INTERFACE OF GENETICS/GENOMICS AND ONCOLOGY PRACTICE
09:55:00 Refreshment Break
10:15:00 KEYNOTE SPEAKER
11:00:00 HEPATOCELLULAR CARCINOMA: FORECAST AND FUTURE
11:20:00 GERO-ONCOLOGY: TRENDS, TREATMENTS AND THOUGHTS
11:40:00 COMBINATION CHEMOTHERAPY AND RADIATION THERAPY IN HEAD AND NECK CANCERS
12:00:00 ECHNOLOGY 2007: QUALITY, COST AND USING INFORMATION TECHNOLOGY EFFECTIVELY Edward P. Ambinder
12:20:00 LUNCH
13:20:00 OVERCOMING LANGUAGE BARRIERS IN HEALTHCARE
13:40:00 SEARCHING FOR MEANING: SPIRITUAL CARE DURING CHEMOTHERAPY
14:00:00 LATE EFFECTS OF PEDIATRIC CANCER
14:20:00 MANAGING END-OF-LIFE DECISIONS
14:40:00 CONTROVERSIES IN THE TREATMENT OF CLL
15:00:00 AWARENESS AND PREVENTION OF OSTEONECROSIS OF THE JAW
15:20:00 INTEGRATIVE MEDICINE: WHAT IT IS AND HOW IT HELPS CANCER CARE Gary E. Deng
15:40:00 TRANSITION FROM TREATMENT TO SURVIVORSHIP
16:00:00 CLOSING REMARKS AND ADJOURN
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.